EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

The impact of opioid use associated with curative‐intent cancer surgery on safe opioid prescribing practice among veterans: An observational study

Marilyn M Schapira, Sumedha Chhatre, Patience M Dow, Charles E Leonard, Peter Groeneveld, Jason M Prigge iD, Christopher Roberts, Zachary F Meisel, Ravi B Parikh, Ravishankar Jayadevappa, Emily C Paulson, Robert S Krouse iD und 4 weitere

Cancer · 2025

DOI: 10.1002/cncr.70009 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cancer, 2025. Verfasst von Marilyn M Schapira und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthcare Evaluation, Research, and Promotion, Corporal Michael J. Crescenz Veterans Affairs (VA) Medical Center, Philadelphia, Pennsylva…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Neoplasms, Postoperative Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: US Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Opioid exposure during cancer therapy may increase long‐term unsafe opioid prescribing. This study sought to determine the rates of coprescription of benzodiazepine and opioid medications and new persistent opioid use after surgical treatment of early‐stage cancer.

Methods

A retrospective cohort study was conducted among a US veteran population via the Veterans Affairs Corporate Data Warehouse database. Participants were opioid‐naive persons aged ≥21 years with a new diagnosis of stage 0–III cancer between January 1, 2015, and December 31, 2016. Outcomes were days of coprescription of benzodiazepines and opioids in the 13 months posttreatment and new persistent opioid use. The exposure was total morphine milligram equivalents (MMEs) attributed to treatment and prescribed from 30 days before through 14 days after the index surgical procedure.

Results

Among 9213 veterans, coprescription of benzodiazepines and opioids occurred in 366 patients (4.0%) and new persistent opioid use in 981 patients (10.6%). In a linear model adjusting for patient, clinical, and geographic factors, persons in the highest quartile compared to no opioid exposure had increased days with coprescription of benzodiazepines and opioids (mean difference, 1.0; 95% CI, 0.3–1.7). In a discrete time survival analysis, persons in the highest quartile of MME exposure compared to none had a greater risk of new persistent opioid use (hazard ratio, 1.6; 95% CI, 1.3–1.9).

Conclusions

More than one of 10 opioid‐naive veterans undergoing curative‐intent surgical treatment for cancer developed new persistent opioid use. Optimizing cancer treatment pain management strategies to mitigate long‐term opioid‐related health risks is crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidPractice Patterns, Physicians'NeoplasmsPostoperative PainCancer PainHumansMaleFemaleVeteransMiddle AgedRetrospective StudiesAgedBenzodiazepinesUnited StatesDrug PrescriptionsAdult

Stichwörter der Autor:innen

cancer survivorshipcurative‐intent surgical cancer treatmentearly‐stage cancernew persistent opioid use

Substanzen

Analgesics, OpioidBenzodiazepines

Autor:innen und Institutionen

  • Center for Healthcare Evaluation, Research, and Promotion, Corporal Michael J. Crescenz Veterans Affairs (VA) Medical Center, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jason M Prigge, Robert S Krouse, Rebecca A Hubbard

Förderung

  • US Department of Veterans Affairs

Zitieren

APA

Schapira, M. M., Chhatre, S., Dow, P. M., Leonard, C. E., Groeneveld, P., Prigge, J. M., Roberts, C., Meisel, Z. F., Parikh, R. B., Jayadevappa, R., Paulson, E. C., Krouse, R. S., Suda, K. J., Kumar, P., Muluk, V., & Hubbard, R. A. (2025). The impact of opioid use associated with curative‐intent cancer surgery on safe opioid prescribing practice among veterans: An observational study. Cancer. https://doi.org/10.1002/cncr.70009

Vancouver

Schapira MM, Chhatre S, Dow PM, Leonard CE, Groeneveld P, Prigge JM, et al. The impact of opioid use associated with curative‐intent cancer surgery on safe opioid prescribing practice among veterans: An observational study. Cancer. 2025. doi:10.1002/cncr.70009

BibTeX
@article{Schapira2025,
  author = {Schapira, Marilyn M and Chhatre, Sumedha and Dow, Patience M and Leonard, Charles E and Groeneveld, Peter and Prigge, Jason M and Roberts, Christopher and Meisel, Zachary F and Parikh, Ravi B and Jayadevappa, Ravishankar and Paulson, Emily C and Krouse, Robert S and Suda, Katie J and Kumar, Pallavi and Muluk, Visala and Hubbard, Rebecca A},
  title = {The impact of opioid use associated with curative‐intent cancer surgery on safe opioid prescribing practice among veterans: An observational study},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70009}
}
Kostenlos starten →